Detalhe da pesquisa
1.
The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly.
Pituitary
; 27(1): 44-51, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064149
2.
The role of elastography in the assessment of thyroid nodules in acromegaly.
Turk J Med Sci
; 53(1): 303-309, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945936
3.
Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
J Autoimmun
; 128: 102809, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220164
4.
The predictive value of hematologic parameters in the risk of thyroid malignancy in cases with atypia/follicular lesion of undetermined significance.
Eur Arch Otorhinolaryngol
; 279(8): 4077-4084, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35006341
5.
The visceral adiposity index, lipid accumulation product, and plasma atherogenic index are associated with subclinical atherosclerosis in patients with newly diagnosed acromegaly.
Turk J Med Sci
; 51(5): 2600-2606, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441155
6.
The evaluation of breast findings detected through different visualisation techniques in acromegaly patients a retrospective study
Turk J Med Sci
; 51(6): 3073-3081, 2021 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34530525
7.
Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism.
Endocrine
; 83(2): 466-472, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922091
8.
Real-time detection of acromegaly from facial images with artificial intelligence.
Eur J Endocrinol
; 188(1)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747333
9.
Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis.
Endocrine
; 79(2): 323-330, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129593
10.
Effect of thyroid nodule size on cytology reliability and incidence of malignancy: A large cohort of 1205 patients from a single center.
Ann Endocrinol (Paris)
; 84(2): 238-241, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126756
11.
Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study.
J Clin Endocrinol Metab
; 108(10): e1013-e1026, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186260
12.
Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination.
Arch Endocrinol Metab
; 66(1): 97-103, 2022 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029854
13.
Subacute thyroiditis paranchime heterogeneity may mask thyroid nodules and higher EU-TIRADS scores.
Endocrine
; 77(2): 291-296, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35553358
14.
Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature.
Arch Endocrinol Metab
; 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612842
15.
Evaluation of the diagnostic features and clinical course of COVID-19 vaccine-associated subacute thyroiditis.
Hormones (Athens)
; 21(3): 447-455, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711078
16.
Cushing's syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review.
Hormones (Athens)
; 21(1): 147-154, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478059
17.
The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology.
Bosn J Basic Med Sci
; 22(1): 118-123, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247569
18.
Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients.
Growth Horm IGF Res
; 67: 101501, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166917
19.
Two Important Issues in Subacute Thyroiditis Management: Delayed Diagnosis and Inappropriate Use of Antibiotics.
Eur Thyroid J
; 10(4): 323-329, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34395304
20.
Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 20(12): 836-842, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958432